UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
|
|
|
|
||
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s Telephone Number, Including Area Code: (
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
|
|
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On October 25, 2023, the Trust made its third quarter, 2023 earnings release. A copy of the Trust’s press release is furnished as exhibit 99.1 to this Form 8-K and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Number |
|
Description |
99.1 |
|
|
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document). |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit Index
Exhibit Number |
|
Description |
99.1 |
|
|
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document). |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
UNIVERSAL HEALTH REALTY INCOME TRUST |
|
|
|
|
|
Date: October 25, 2023 |
|
By: |
/s/ Charles F. Boyle |
|
|
Name: |
Charles F. Boyle |
|
|
Title: |
Senior Vice President and Chief Financial Officer |
Exhibit 99.1
UNIVERSAL HEALTH REALTY INCOME TRUST |
|
Universal Corporate Center |
||
|
|
|
|
367 S. Gulph Road |
|
|
|
|
P.O. Box 61558 |
|
|
|
|
King of Prussia, PA 19406 |
|
|
|
|
(610) 265-0688 |
|
||||
FOR IMMEDIATE RELEASE |
||||
CONTACT: |
|
Charles Boyle |
|
October 25, 2023 |
|
|
Chief Financial Officer |
|
|
|
|
(610) 768-3300 |
|
|
UNIVERSAL HEALTH REALTY INCOME TRUST
REPORTS 2023 THIRD QUARTER FINANCIAL RESULTS
Consolidated Results of Operations - Three-Month Periods Ended September 30, 2023 and 2022:
KING OF PRUSSIA, PA - Universal Health Realty Income Trust (NYSE:UHT) announced today that for the three-month period ended September 30, 2023, net income was $3.9 million, or $.28 per diluted share, as compared to $4.8 million, or $.35 per diluted share, during the third quarter of 2022.
The decrease in our net income of $976,000, or $.07 per diluted share, during the third quarter of 2023, as compared to the comparable quarter of 2022, consisted of the following: (i) a decrease of $1.6 million, or $.12 per diluted share, resulting from an increase in interest expense due to increases in our average borrowing rate and average outstanding borrowings, partially offset by; (ii) an increase of $672,000, or $.05 per diluted share, resulting from an aggregate net increase in the income generated at various properties.
As calculated on the attached Schedule of Non-GAAP Supplemental Information (“Supplemental Schedule”), our funds from operations ("FFO") were $11.2 million, or $.81 per diluted share, during the third quarter of 2023, as compared to $11.8 million, or $.86 per diluted share during the third quarter of 2022. The decrease of $608,000, or $.05 per diluted share, was due primarily to the above-mentioned decrease in our net income during the third quarter of 2023, as compared to the third quarter of 2022, partially offset by an increase in depreciation and amortization expense.
Consolidated Results of Operations - Nine-Month Periods Ended September 30, 2023 and 2022:
For the nine-month period ended September 30, 2023, net income was $11.8 million, or $0.85 per diluted share, as compared to $15.5 million, or $1.12 per diluted share during the first nine months of 2022.
The decrease in our net income of $3.7 million, or $.27 per diluted share, during the first nine months of 2023, as compared to the comparable period of 2022, was primarily due to: (i) a decrease of $4.9 million, or $.36 per diluted share, resulting from an increase in interest expense due to increases in our average borrowing rate and average outstanding borrowings; (ii) a decrease of $1.1 million, or $.08 per diluted share, from demolition expenses incurred during the first nine months of 2023 related to a property located in Chicago, Illinois, partially offset by; (iii) a net increase of $2.4 million, or $.17 per diluted share, resulting from an aggregate net increase in the income generated at various properties, including a reduction of $686,000, or $.05 per diluted share, in the non-demolition related operating expenses incurred in connection with the property located in Chicago.
As calculated on the attached Supplemental Schedule, our FFO were $33.2 million, or $2.40 per diluted share, during the first nine months of 2023, as compared to $36.4 million, or $2.64 per diluted share during the comparable period of 2022. The decrease of $3.2 million, or $.24 per diluted share, was due primarily to the above-mentioned decrease in our net income during the first nine months of 2023, as compared to the first nine months of 2022, partially offset by an increase in depreciation and amortization expense.
Dividend Information:
The third quarter dividend of $.72 per share, or $9.9 million in the aggregate, was declared on September 6, 2023 and paid on September 29, 2023.
Capital Resources Information:
At September 30, 2023, we had $321.5 million of borrowings outstanding pursuant to the terms of our $375 million revolving credit agreement and $50.4 million of available borrowing capacity as of that date, net of outstanding borrowings and letters of credit.
Property Acquisition:
In August, 2023, we acquired the McAllen Doctor's Center, a medical office building ("MOB") located in McAllen, Texas for a purchase price of approximately $7.5 million. The building has approximately 79,500 rentable square feet and is 100% master leased to McAllen Hospitals, L.P, a wholly-owned subsidiary of UHS. The triple-net master lease is for twelve years and is scheduled to expire on August 31, 2035. McAllen Hospitals, L.P. has the option to renew the lease term for three consecutive ten-year terms. The initial annual base rent is approximately $624,000. This acquisition was completed utilizing a qualified third-party intermediary as part of an anticipated tax-deferred like-kind-exchange transaction pursuant to Section 1031 of the Internal Revenue Code, as amended.
New Construction Project - Sierra Medical Plaza I:
In March, 2023, construction was substantially completed on the Sierra Medical Plaza I, an 86,000 square foot MOB located in Reno, Nevada. This MOB is located on the campus of the Northern Nevada Sierra Medical Center, a hospital that is owned and operated by a wholly-owned subsidiary of UHS, which was completed and opened during April, 2022. The master flex lease agreement in connection with this building, which commenced in March, 2023 and has a ten-year term scheduled to expire on March 31, 2033, covers approximately 68% of the rentable square feet of the MOB at an initial minimum rent of $1.3 million annually, plus a pro-rata share of the common area maintenance expenses. This master flex lease agreement is subject to reduction based upon the execution of third-party leases. The aggregate cost of the MOB is estimated to be approximately $35 million, approximately $26 million of which was incurred as of September 30, 2023.
Vacant Specialty Facilities:
Demolition of the former specialty hospital located in Chicago, Illinois, has been substantially completed. Demolition costs were approximately $1.5 million in the aggregate, nearly all of which was incurred as of June 30, 2023. These demolition costs were included in other operating expenses in our consolidated statements of income during the following periods: $332,000 during the fourth quarter of 2022, $265,000 during the first quarter of 2023 and $862,000 during the second quarter of 2023.
Including the above-mentioned demolition costs incurred during the nine-months ended September 30, 2023, the operating expenses incurred by us in connection with the property located in Chicago, Illinois, were $129,000 and $1.5 million during the three and nine-months ended September 30, 2023, respectively, (or $129,000 and $401,000 during the three and nine-months ended September 30, 2023,
respectively, excluding the demolition costs) as compared to $240,000 and $1.1 million during the three and nine-month periods ended September 30, 2022, respectively.
In addition, the aggregate operating expenses for the two vacant specialty facilities located in Evansville, Indiana, and Corpus Christi, Texas, were approximately $183,000 and $167,000 during the three-month periods ended September 30, 2023 and 2022, respectively, and approximately $572,000 and $540,000 during the nine-month periods ended September 30, 2023 and 2022, respectively.
We continue to market the three above-mentioned properties to third parties. Future operating expenses related to these properties, which are estimated to be approximately $1.3 million in the aggregate during the full year of 2023 (excluding the demolition costs incurred in connection with the property in Chicago, Illinois), will be incurred by us during the time they remain owned and unleased. Should these properties continue to remain owned and unleased for an extended period of time, or should we incur substantial renovation or additional demolition costs to make the properties suitable for other operators/tenants/buyers, our future results of operations could be materially unfavorably impacted.
General Information, Forward-Looking Statements and Risk Factors and Non-GAAP Financial Measures:
Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human-service related facilities including acute care hospitals, behavioral health care hospitals, specialty facilities, medical/office buildings, free-standing emergency departments and childcare centers. We have investments or commitments in seventy-seven properties located in twenty-one states.
This press release contains forward-looking statements based on current management expectations. Numerous factors, including those disclosed herein, as well as the operations and financial results of each of our tenants, those related to healthcare industry trends and those detailed in our filings with the Securities and Exchange Commission (as set forth in Item 1A-Risk Factors and in Item 7- Forward-Looking Statements in our Form 10-K for the year ended December 31, 2022 and in Item 7- Forward-Looking Statements and Certain Risk Factors in our Form 10-Q for the quarter ended June 30, 2023), may cause the results to differ materially from those anticipated in the forward-looking statements. Readers should not place undue reliance on such forward-looking statements which reflect management’s view only as of the date hereof. We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Many of the factors that could affect our future results are beyond our control or ability to predict, including the impact of the COVID-19 pandemic. Future operations and financial results of our tenants, and in turn ours, could be materially impacted by various developments including, but not limited to, decreases in staffing availability and related increases to wage expense experienced by our tenants resulting from the nationwide shortage of nurses and other clinical staff and support personnel, the impact of government and administrative regulation of the health care industry; declining patient volumes and unfavorable changes in payer mix caused by deteriorating macroeconomic conditions (including increases in uninsured and underinsured patients as the result of business closings and layoffs); potential disruptions related to supplies required for our tenants’ employees and patients; and potential increases to other expenditures.
In addition, the increase in interest rates has substantially increased our borrowings costs and reduced our ability to access the capital markets on favorable terms. Additional increases in interest rates could have a significant unfavorable impact on our future results of operations and the resulting effect on the capital markets could adversely affect our ability to carry out our strategy.
We believe that, if and when applicable, adjusted net income and adjusted net income per diluted share (as reflected on the Supplemental Schedule), which are non-GAAP financial measures (“GAAP” is Generally Accepted Accounting Principles in the United States of America), are helpful to our investors as measures of our operating performance. In addition, we believe that, when applicable, comparing and discussing our financial results based on these measures, as calculated, is helpful to our investors since it neutralizes the effect in each year of material items that are non-recurring or non-operational in nature including items such as, but not limited to, gains on transactions.
Funds from operations (“FFO”) is a widely recognized measure of performance for Real Estate Investment Trusts (“REITs”). We believe that FFO and FFO per diluted share, which are non-GAAP financial measures, are helpful to our investors as measures of our operating performance. We compute FFO, as reflected on the attached Supplemental Schedules, in accordance with standards established by the National Association of Real Estate Investment Trusts (“NAREIT”), which may not be comparable to FFO reported by other REITs that do not compute FFO in accordance with the NAREIT definition, or that interpret the NAREIT definition differently than we interpret the definition. FFO adjusts for the effects of certain items, such as gains on transactions that occurred during the periods presented. FFO does not represent cash generated from operating activities in accordance with GAAP and should not be considered to be an alternative to net income determined in accordance with GAAP. In addition, FFO should not be used as: (i) an indication of our financial performance determined in accordance with GAAP; (ii) an alternative to cash flow from operating activities determined in accordance with GAAP; (iii) a measure of our liquidity, or; (iv) an indicator of funds available for our cash needs, including our ability to make cash distributions to shareholders. A reconciliation of our reported net income to FFO is reflected on the Supplemental Schedules included below.
To obtain a complete understanding of our financial performance these measures should be examined in connection with net income, determined in accordance with GAAP, as presented in the condensed consolidated financial statements and notes thereto in this report or in our other filings with the Securities and Exchange Commission including our Report on Form 10-K for the year ended December 31, 2022 and our Report on Form 10-Q for the quarter ended June 30, 2023. Since the items included or excluded from these measures are significant components in understanding and assessing financial performance under GAAP, these measures should not be considered to be alternatives to net income as a measure of our operating performance or profitability. Since these measures, as presented, are not determined in accordance with GAAP and are thus susceptible to varying calculations, they may not be comparable to other similarly titled measures of other companies. Investors are encouraged to use GAAP measures when evaluating our financial performance.
(more)
Universal Health Realty Income Trust
Consolidated Statements of Income
For the Three and Nine Months Ended September 30, 2023 and 2022
(amounts in thousands, except share information)
(unaudited)
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
September 30, |
|
|
September 30, |
|
||||||||||
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
||||
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Lease revenue - UHS facilities (a.) |
|
$ |
8,274 |
|
|
$ |
7,471 |
|
|
$ |
24,297 |
|
|
$ |
22,291 |
|
Lease revenue - Non-related parties |
|
|
13,926 |
|
|
|
12,836 |
|
|
|
40,955 |
|
|
|
38,664 |
|
Other revenue - UHS facilities |
|
|
254 |
|
|
|
255 |
|
|
|
730 |
|
|
|
717 |
|
Other revenue - Non-related parties |
|
|
404 |
|
|
|
221 |
|
|
|
1,177 |
|
|
|
718 |
|
Interest income on financing leases - UHS facilities |
|
|
1,365 |
|
|
|
1,368 |
|
|
|
4,096 |
|
|
|
4,107 |
|
|
|
|
24,223 |
|
|
|
22,151 |
|
|
|
71,255 |
|
|
|
66,497 |
|
Expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Depreciation and amortization |
|
|
7,012 |
|
|
|
6,658 |
|
|
|
20,479 |
|
|
|
20,046 |
|
Advisory fees to UHS |
|
|
1,332 |
|
|
|
1,297 |
|
|
|
3,957 |
|
|
|
3,787 |
|
Other operating expenses |
|
|
7,854 |
|
|
|
6,875 |
|
|
|
23,625 |
|
|
|
20,728 |
|
|
|
|
16,198 |
|
|
|
14,830 |
|
|
|
48,061 |
|
|
|
44,561 |
|
Income before equity in income of unconsolidated limited liability companies ("LLCs") and interest expense |
|
|
8,025 |
|
|
|
7,321 |
|
|
|
23,194 |
|
|
|
21,936 |
|
Equity in income of unconsolidated LLCs |
|
|
314 |
|
|
|
346 |
|
|
|
953 |
|
|
|
943 |
|
Interest expense, net |
|
|
(4,467 |
) |
|
|
(2,819 |
) |
|
|
(12,340 |
) |
|
|
(7,408 |
) |
Net income |
|
$ |
3,872 |
|
|
$ |
4,848 |
|
|
$ |
11,807 |
|
|
$ |
15,471 |
|
Basic earnings per share |
|
$ |
0.28 |
|
|
$ |
0.35 |
|
|
$ |
0.86 |
|
|
$ |
1.12 |
|
Diluted earnings per share |
|
$ |
0.28 |
|
|
$ |
0.35 |
|
|
$ |
0.85 |
|
|
$ |
1.12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Weighted average number of shares outstanding - Basic |
|
|
13,790 |
|
|
|
13,776 |
|
|
|
13,784 |
|
|
|
13,769 |
|
Weighted average number of shares outstanding - Diluted |
|
|
13,822 |
|
|
|
13,801 |
|
|
|
13,811 |
|
|
|
13,792 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
(a.) Includes bonus rental on McAllen Medical Center, a UHS acute care hospital facility of $725 and $727 for the three-month periods ended September 30, 2023 and 2022, respectively, and $2,219 and $2,048 for the nine-month periods ended September 30, 2023 and 2022, respectively. |
|
|||||||||||||||
Universal Health Realty Income Trust
Schedule of Non-GAAP Supplemental Information (“Supplemental Schedule”)
For the Three Months Ended September 30, 2023 and 2022
(amounts in thousands, except share information)
(unaudited)
Calculation of Adjusted Net Income
|
|
Three Months Ended |
|
|
Three Months Ended |
|
||||||||||
|
|
September 30, 2023 |
|
|
September 30, 2022 |
|
||||||||||
|
|
Amount |
|
|
Per |
|
|
Amount |
|
|
Per |
|
||||
Net income |
|
$ |
3,872 |
|
|
$ |
0.28 |
|
|
$ |
4,848 |
|
|
$ |
0.35 |
|
Adjustments |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Subtotal adjustments to net income |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Adjusted net income |
|
$ |
3,872 |
|
|
$ |
0.28 |
|
|
$ |
4,848 |
|
|
$ |
0.35 |
|
Calculation of Funds From Operations (“FFO”)
|
|
Three Months Ended |
|
|
Three Months Ended |
|
||||||||||
|
|
September 30, 2023 |
|
|
September 30, 2022 |
|
||||||||||
|
|
Amount |
|
|
Per |
|
|
Amount |
|
|
Per |
|
||||
Net income |
|
$ |
3,872 |
|
|
$ |
0.28 |
|
|
$ |
4,848 |
|
|
$ |
0.35 |
|
Plus: Depreciation and amortization expense: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Consolidated investments |
|
|
7,012 |
|
|
|
0.51 |
|
|
|
6,658 |
|
|
|
0.49 |
|
Unconsolidated affiliates |
|
|
309 |
|
|
|
0.02 |
|
|
|
295 |
|
|
|
0.02 |
|
FFO |
|
$ |
11,193 |
|
|
$ |
0.81 |
|
|
$ |
11,801 |
|
|
$ |
0.86 |
|
Dividend paid per share |
|
|
|
|
$ |
0.720 |
|
|
|
|
|
$ |
0.710 |
|
||
Universal Health Realty Income Trust
Schedule of Non-GAAP Supplemental Information (“Supplemental Schedule”)
For the Nine Months Ended September 30, 2023 and 2022
(amounts in thousands, except share information)
(unaudited)
Calculation of Adjusted Net Income
|
|
Nine Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
September 30, 2023 |
|
|
September 30, 2022 |
|
||||||||||
|
|
Amount |
|
|
Per |
|
|
Amount |
|
|
Per |
|
||||
Net income |
|
$ |
11,807 |
|
|
$ |
0.85 |
|
|
$ |
15,471 |
|
|
$ |
1.12 |
|
Adjustments |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Subtotal adjustments to net income |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Adjusted net income |
|
$ |
11,807 |
|
|
$ |
0.85 |
|
|
$ |
15,471 |
|
|
$ |
1.12 |
|
Calculation of Funds From Operations (“FFO”)
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
Nine Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
September 30, 2023 |
|
|
September 30, 2022 |
|
||||||||||
|
|
Amount |
|
|
Per |
|
|
Amount |
|
|
Per |
|
||||
Net income |
|
$ |
11,807 |
|
|
$ |
0.85 |
|
|
$ |
15,471 |
|
|
$ |
1.12 |
|
Plus: Depreciation and amortization expense: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Consolidated investments |
|
|
20,479 |
|
|
|
1.48 |
|
|
|
20,046 |
|
|
|
1.46 |
|
Unconsolidated affiliates |
|
|
900 |
|
|
|
0.07 |
|
|
|
885 |
|
|
|
0.06 |
|
FFO |
|
$ |
33,186 |
|
|
$ |
2.40 |
|
|
$ |
36,402 |
|
|
$ |
2.64 |
|
Dividend paid per share |
|
|
|
|
$ |
2.155 |
|
|
|
|
|
$ |
2.125 |
|
||
Universal Health Realty Income Trust
Consolidated Balance Sheets
(amounts in thousands, except share information)
(unaudited)
|
|
September 30, |
|
|
December 31, |
|
||
|
|
2023 |
|
|
2022 |
|
||
Assets: |
|
|
|
|
|
|
||
Real Estate Investments: |
|
|
|
|
|
|
||
Buildings and improvements and construction in progress |
|
$ |
650,670 |
|
|
$ |
641,338 |
|
Accumulated depreciation |
|
|
(258,584 |
) |
|
|
(248,772 |
) |
|
|
|
392,086 |
|
|
|
392,566 |
|
Land |
|
|
57,975 |
|
|
|
56,631 |
|
Net Real Estate Investments |
|
|
450,061 |
|
|
|
449,197 |
|
Financing receivable from UHS |
|
|
83,362 |
|
|
|
83,603 |
|
Net Real Estate Investments and Financing receivable |
|
|
533,423 |
|
|
|
532,800 |
|
Investments in and advances to limited liability companies ("LLCs") |
|
|
9,329 |
|
|
|
9,282 |
|
Other Assets: |
|
|
|
|
|
|
||
Cash and cash equivalents |
|
|
8,359 |
|
|
|
7,614 |
|
Lease and other receivables from UHS |
|
|
6,033 |
|
|
|
5,388 |
|
Lease receivable - other |
|
|
8,541 |
|
|
|
8,445 |
|
Intangible assets (net of accumulated amortization of $12.6 million and |
|
|
9,650 |
|
|
|
9,447 |
|
Right-of-use land assets, net |
|
|
10,952 |
|
|
|
11,457 |
|
Deferred charges and other assets, net |
|
|
21,596 |
|
|
|
23,107 |
|
Total Assets |
|
$ |
607,883 |
|
|
$ |
607,540 |
|
Liabilities: |
|
|
|
|
|
|
||
Line of credit borrowings |
|
$ |
321,500 |
|
|
$ |
298,100 |
|
Mortgage notes payable, non-recourse to us, net |
|
|
39,319 |
|
|
|
44,725 |
|
Accrued interest |
|
|
330 |
|
|
|
373 |
|
Accrued expenses and other liabilities |
|
|
13,808 |
|
|
|
12,873 |
|
Ground lease liabilities, net |
|
|
10,952 |
|
|
|
11,457 |
|
Tenant reserves, deposits and deferred and prepaid rents |
|
|
11,666 |
|
|
|
10,911 |
|
Total Liabilities |
|
|
397,575 |
|
|
|
378,439 |
|
Equity: |
|
|
|
|
|
|
||
Preferred shares of beneficial interest, |
|
|
- |
|
|
|
- |
|
Common shares, $.01 par value; |
|
|
138 |
|
|
|
138 |
|
Capital in excess of par value |
|
|
270,166 |
|
|
|
269,472 |
|
Cumulative net income |
|
|
822,468 |
|
|
|
810,661 |
|
Cumulative dividends |
|
|
(892,954 |
) |
|
|
(863,181 |
) |
Accumulated other comprehensive income |
|
|
10,490 |
|
|
|
12,011 |
|
Total Equity |
|
|
210,308 |
|
|
|
229,101 |
|
Total Liabilities and Equity |
|
$ |
607,883 |
|
|
$ |
607,540 |
|
Document and Entity Information |
Oct. 25, 2023 |
|---|---|
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Oct. 25, 2023 |
| Entity Registrant Name | UNIVERSAL HEALTH REALTY INCOME TRUST |
| Entity Central Index Key | 0000798783 |
| Entity Emerging Growth Company | false |
| Entity File Number | 1-9321 |
| Entity Incorporation, State or Country Code | MD |
| Entity Tax Identification Number | 23-6858580 |
| Entity Address, Address Line One | Universal Corporate Center |
| Entity Address, Address Line Two | 367 South Gulph Road |
| Entity Address, City or Town | King of Prussia |
| Entity Address, State or Province | PA |
| Entity Address, Postal Zip Code | 19406 |
| City Area Code | 610 |
| Local Phone Number | 265-0688 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Shares of beneficial interest, $0.01 par value |
| Trading Symbol | UHT |
| Security Exchange Name | NYSE |